Rapid Test Ag 2019-nCoV (PROGNOSIS, BIOTECH, Larissa, Greece); Performance Evaluation in Hospital Setting with Real Time RT-PCR.
Maria KyritsiAlexandros VontasIoanna VoulgaridiAlexia MatziriApostolos KomnosDimitris BabalisAntonios PapadogoulasAikaterini OikonomouVarvara A MouchtouriMatthaios SpeletasChristos S HadjichristodoulouPublished in: International journal of environmental research and public health (2021)
The Rapid Test Ag 2019-nCoV demonstrated sufficient sensitivity, excellent specificity and could be available to be used with low overall cost. Thus, it could be used as point of care test, but also for mass screening for rapid detection of infected persons (e.g., for travelers).